Butterfly Learnings, a platform for paediatric behavioural and developmental health, revealed the closure of its series A funding round, securing Rs 32 crore.
The funding was led by Insitor Impact Asia Fund II and Enzia Ventures, with additional contributions from CIIE (IIMA Ventures), Foundation Botnar, 9 Unicorns, and Venture Catalysts.
The company plans to use the funds to “extend its reach across multiple states and cities in India through a 200-center network,” it said in a statement. It operates 30 centers in Maharashtra and caters to around 2,000 families.
Established in 2021, Butterfly Learnings secured $2 million in seed funding in 2022 from investors including Insitor Partners, 9 Unicorns, Venture Catalysts, Fondation Botnar, UTIL Stiftung, Enzia Ventures, and CIIE.CO.
Based in Mumbai, the company functions as a comprehensive phygital platform, offering customized assistance to children and families confronting challenges linked to neurodiversity. It employs over 250 trained therapists in-house and extends its operations to urban areas like Pune, Nagpur, and Nasik.
“The infusion of funds will fuel Butterfly Learnings’ expansion efforts as it aims to scale its technology-enabled therapy programs to equip neuro-diverse children to integrate with society and manage their lives better,” the company said.
Butterfly Learnings’ cofounder and CEO, Sonam Kothari, emphasized that the injected funds will accelerate the company’s mission and facilitate the faster implementation of its solutions.
“With our distinctive blend of technology enabled therapy delivery and focus on clinical excellence, we remain dedicated to ensuring that every child receives the support they need to thrive and grow,” Kothari said.
The platform, accredited by QABA and BHCOE, delivers personalized therapy plans rooted in applied behavior analysis (ABA). It offers consultations with pediatric neurologists or developmental pediatricians, occupational therapy, speech therapy, oral placement therapy, and sensory integration.
Karuna Jain, the partner at Enzia Ventures, said, “With this network, Butterfly will provide therapy to children across socio-economic strata but, more importantly, provide access to outcomes-linked, personalized therapy to each child. Personalization of therapy and measurement of therapy outcomes is a global need. In India, this need is more pronounced with most parents only having access to speech and occupational therapists, and having no expectation setting or outcome measurement. We are already seeing strong demand across centers and only expect this to pick up more as diagnosis of developmental disorders and quality appreciation for therapy goes up.”
Insitor Impact Asia Fund II’s cofounder and CIO, Nicholas Lazos, highlighted that in India, nearly 3 million children are affected by autism, with one in eight children aged between 2 and 9 experiencing at least one neurodevelopmental disorder.
“Unfortunately, the small number of standalone clinics currently available to parents lack a rigorous scientific approach to therapy provision,” Lazos said, adding that Butterfly Learnings’ founders leveraged their extensive clinical and technological expertise to offer an evidence-based, technology-enabled therapy solution for children.”
